NEW YORK (360Dx) – Bruker said last week it has acquired a portable immunoassay-based platform for the rapid detection of bacteria, viruses, and toxins.

The company did not disclose the purchase price or the company from which it acquired the technology, but said in a statement that the assets include "intellectual property, a field-portable, electrochemical chip-based detection instrument, and associated consumable kits."

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.